Skip to content

OTC · CIK 0000315545

PVCT PROVECTUS BIOPHARMACEUTICALS, INC.

Insider trading from SEC Form 4. Last filing 8 d ago.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company

Signals

Open-market buys and sells at PROVECTUS BIOPHARMACEUTICALS, INC., scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

The last 80 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 3, 2026Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--8 d ago
Oct 3, 2026Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+13,216$0.00$02,975,9258 d ago
Sep 18, 2026Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--25 d ago
Sep 18, 2026Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+13,216$0.00$02,962,70925 d ago
Sep 11, 2026Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--32 d ago
Sep 11, 2026Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+13,216$0.00$02,949,49332 d ago
Sep 4, 2026Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--35 d ago
Sep 4, 2026Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+11,328$0.00$02,936,27735 d ago
Jun 30, 2026Webster Bailey
director
AGrant or award
Series D-1 Convertible Preferred Stockderivative
+48,917$0.00$0207,535Jun 30, 2026
Mar 25, 2026Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Mar 26, 2026
Mar 20, 2026Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Mar 20, 2026
Mar 20, 2026Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+49,067$0.00$02,710,054Mar 20, 2026
Mar 12, 2026Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Mar 16, 2026
Mar 5, 2026Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Mar 6, 2026
Feb 26, 2026Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Feb 27, 2026
Feb 20, 2026Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Feb 23, 2026
Feb 19, 2026Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Feb 23, 2026
Feb 20, 2026Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+47,180$0.00$02,660,987Feb 23, 2026
Feb 12, 2026Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Feb 17, 2026
Feb 9, 2026Edward Pershing
CEO
POpen-market purchase
Series D-1 Convertible Preferred Stockderivative
+34,940$2.86$100k2,613,807Feb 11, 2026
Feb 5, 2026Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Feb 9, 2026
Jan 30, 2026Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Feb 2, 2026
Jan 30, 2026Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+37,744$0.00$02,578,867Feb 2, 2026
Jan 28, 2026Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Jan 29, 2026
Jan 16, 2026Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Jan 16, 2026
Jan 16, 2026Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+37,744$0.00$02,541,123Jan 16, 2026
Dec 11, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Dec 15, 2025
Dec 5, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Dec 8, 2025
Nov 26, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Nov 28, 2025
Nov 20, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Nov 21, 2025
Nov 13, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Nov 14, 2025
Nov 6, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Nov 7, 2025
Oct 30, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Oct 31, 2025
Oct 23, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Oct 24, 2025
Oct 16, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Oct 17, 2025
Oct 16, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+18,880$0.00$02,503,379Oct 17, 2025
Oct 10, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Oct 14, 2025
Oct 3, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Oct 9, 2025
Sep 30, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Sep 30, 2025
Sep 30, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+66,052$0.00$02,484,499Sep 30, 2025
Sep 19, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Sep 19, 2025
Sep 18, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Sep 19, 2025
Sep 19, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+37,760$0.00$02,418,447Sep 19, 2025
Sep 11, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Sep 12, 2025
Sep 4, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Sep 5, 2025
Aug 29, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Aug 29, 2025
Aug 29, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+28,320$0.00$02,380,687Aug 29, 2025
Aug 26, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Aug 27, 2025
Aug 22, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Aug 22, 2025
Aug 22, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+37,760$0.00$02,352,367Aug 22, 2025
Aug 8, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Aug 12, 2025
Aug 8, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+18,880$0.00$02,314,607Aug 12, 2025
Jul 18, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Jul 21, 2025
Jul 18, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+62,303$0.00$02,295,727Jul 21, 2025
Jun 26, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Jun 26, 2025
Jun 26, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+122,692$0.00$02,233,424Jun 26, 2025
Jun 20, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Jun 23, 2025
Jun 20, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+18,880$0.00$02,110,732Jun 23, 2025
Jun 5, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Jun 6, 2025
May 23, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--May 27, 2025
May 15, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--May 15, 2025
May 7, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--May 8, 2025
Apr 29, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--May 2, 2025
Apr 29, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+18,876$0.00$02,091,852May 2, 2025
Apr 29, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Apr 30, 2025
Apr 19, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Apr 21, 2025
Apr 19, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+9,438$0.00$02,072,976Apr 21, 2025
Apr 11, 2025Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Apr 16, 2025
Apr 11, 2025Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+7,551$0.00$02,063,538Apr 16, 2025
Apr 4, 2025Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Apr 8, 2025
Dec 2, 2024John Lacey III
director
AGrant or award
Stock Options (Right to Buy)derivative
+775,082$0.00$0775,082Dec 4, 2024
Dec 2, 2024Eric Wachter Phd
CTO
AGrant or award
Stock Options (Right to Buy)derivative
+2,138,548$0.00$02,138,548Dec 4, 2024
Dec 2, 2024Heather Raines
CFO
AGrant or award
Stock Options (Right to Buy)derivative
+4,197,890$0.00$04,197,890Dec 4, 2024
Dec 2, 2024Dominic Rodrigues
President
AGrant or award
Stock Options (Right to Buy)derivative
+16,146,600$0.00$016,146,600Dec 4, 2024
Dec 2, 2024Edward Pershing
CEO
AGrant or award
Stock Options (Right to Buy)derivative
+25,470,215$0.00$025,470,215Dec 4, 2024
Dec 2, 2024Webster Bailey
director
AGrant or award
Stock Options (Right to Buy)derivative
+775,082$0.00$0775,082Dec 4, 2024
Nov 29, 2024Edward Pershing
CEO
MOption exercise
8% Unsecured Convertible Promissory Notederivative
-$0.00--Dec 2, 2024
Nov 29, 2024Edward Pershing
CEO
MOption exercise
Series D-1 Convertible Preferred Stockderivative
+18,880$0.00$01,710,584Dec 2, 2024
Nov 22, 2024Edward Pershing
CEO
POpen-market purchase
Series D-1 Convertible Preferred Stockderivative
+80,365$2.86$230k1,691,704Nov 25, 2024
Oct 16, 2024Edward Pershing
CEO
AGrant or award
8% Unsecured Convertible Promissory Notederivative
-$0.00--Oct 17, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

PVCT insider trading: PROVECTUS BIOPHARMACEUTICALS, INC. | InsiderTell